Skip to search formSkip to main contentSkip to account menu

Triptorelin

Known as: triptorelina, pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2, TRIP 
A synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency than endogenous LHRH, triptorelin… 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (3)

AY-25650DecapeptylTriptorelin Acetate
NCIt Antineoplastic Agent TerminologyTriptorelin 22.5 MG InjectionTriptorelin Acetate 100 ug in 1 mL VAGINAL GEL [OvuGel]cyproterone/triptorelin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
BACKGROUND Heavy menstrual bleeding is one of the most common reasons for referral of premenopausal women to a gynaecologist… 
2010
2010
Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline
Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer… 
2002
2002
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
Highly Cited
1990
Highly Cited
1990
Inhibitory effects of analogs of luteinizing hormone‐releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regression
Syrian golden hamsters bearing N‐nitrosobis(2‐oxopropyl)amine (BOP)‐induced pancreatic carcinomas were treated for 2 months with… 
1990
1990
GnRH receptors in rat brain, pituitary and testis; modulation following surgical and gonadotropin-releasing hormone agonist-induced castration
1989
1989
Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
Antitumoral effects of the agonist of luteinizing hormone-releasing hormone (D-Trp-6-LH-RH) and the somatostatin analog RC-160 (D… 
1989
1989
Influence of D-Trp-6-LH-RH on the survival time in patients with advanced pancreatic cancer.
1989
1989
The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone.
Review
1988
Review
1988
Therapy of advanced ovarian cancer with D-Trp-6-LH-RH (decapeptyl) microcapsules.
Forty-one patients with advanced ovarian cancer (FIGO stage III or IV) who had relapsed following conventional treatment were… 
1985
1985
Advanced ovarian carcinoma: response to the agonist D-Trp-6-LHRH.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)